CARTER WALLACE INC /DE/
10-Q, EX-27, 2000-08-03
PHARMACEUTICAL PREPARATIONS
Previous: CARTER WALLACE INC /DE/, 10-Q, 2000-08-03
Next: CHATTEM INC, 4, 2000-08-03



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-2001
<PERIOD-END>                               JUN-30-2000
<CASH>                                      53,035,000
<SECURITIES>                                26,863,000
<RECEIVABLES>                              185,730,000
<ALLOWANCES>                                 8,999,000
<INVENTORY>                                 98,758,000
<CURRENT-ASSETS>                           403,440,000
<PP&E>                                     335,834,000
<DEPRECIATION>                             183,704,000
<TOTAL-ASSETS>                             793,179,000
<CURRENT-LIABILITIES>                      183,135,000
<BONDS>                                     57,336,000
                                0
                                          0
<COMMON>                                    47,205,000
<OTHER-SE>                                 359,567,000
<TOTAL-LIABILITY-AND-EQUITY>               793,179,000
<SALES>                                    224,508,000
<TOTAL-REVENUES>                           228,060,000
<CGS>                                       77,484,000
<TOTAL-COSTS>                              191,392,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,145,000
<INCOME-PRETAX>                             36,668,000
<INCOME-TAX>                                14,301,000
<INCOME-CONTINUING>                         22,367,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                22,367,000
<EPS-BASIC>                                      .49
<EPS-DILUTED>                                      .48


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission